SEEC 2015

The 6th Southeast European Conference on Chemotherapy and Infection (SEEC) will take place 13-15 November 2015, Porto Palace Hotel, Thessaloniki, Greece. This meeting is held under the auspices of the ISC and the Federation of the European Societies of Chemotherapy and Infection (FESCI).

This years annual conference focuses on the treatment of Infection and Cancer by the performance of the appropriate Antimicrobial and Anticancer Chemotherapy, in south-eastern Europe. It's aim is promotion of new knowledge and collaboration of scientists working in this field and region of SE Europe.

The International Scientific Committee will prepare a scientific program that will cover a broad spectrum of topics. Experts in basic and clinical sciences will shed new light on the latest developments in the fields of infectious diseases and oncology. On behalf of the International Scientific Committee we invite you to actively participate and share your knowledge with colleagues.

The ISC are delighted to have had considerable input into the Scientific Programme from it's Working Groups.  Please view the current Scientific Programme HERE.

Abstract deadline is 15th September, to submit your abstract please click HERE.  Topics include - 

• Microbial resistance in SE Europe and other Mediterranean countries
• Endemic and emerging infectious diseases in Balkan and Mediterranean countries
• Antibiotic prescribing policies , consumption and microbial resistance in European and non-European countries
• Epidemiology of Invasive Fungal Infections
• Newer antifungals
• Hepatitis B and C in SE Europe and other Mediterranean countries
• Epidemiology and treatment of HIV and other STDs
• Infection and Cancer is there a relation?
• Novel anti-Gram positive and anti-Gram negative agents
• Vaccinations myths and realities
• Nosocomial infection and infection control in the era of MDR pathogens
• Clinical trials and research centers network for bringing new anti-infective agents into medical practice
• Progress in the anticancer treatment
• Newer guidelines for the treatment of infections in cancer and other immunocompromised patients
• Colonization vs infection of patients in health care facilities
• Infections in critically Ill patients
• Bone and soft tissue complicated infections